Measure Summaries
Centers for Medicare & Medicaid Services
- End stage renal disease (ESRD): adjusted percentage of adult hemodialysis patient-months using an autogenous arteriovenous fistula (AVF) as the sole means of vascular access.
- End stage renal disease (ESRD): percentage of adult hemodialysis patient-months using a catheter continuously for three months or longer for vascular access.
- End stage renal disease (ESRD): percentage of all adult (greater than or equal to 18 years old) patient-months who were on ESRD treatment for 91 days or more and dialyzed greater than 2 and less than 4 times weekly whose delivered dose of hemodialysis (calculated from the last measurements of the month using the UKM or Daugirdas II formula) was a spKt/V greater than or equal to 1.2 during the study period. This updates a previously published measure summary.
- End stage renal disease (ESRD): percentage of all patient-months for patients whose delivered dose of dialysis (either hemodialysis or peritoneal dialysis) met the specified threshold during the reporting period.
- End stage renal disease (ESRD): percentage of all pediatric (less than 18 years old) patient-months who were on ESRD treatment for 91 days or more, and dialyzing greater than 2 or less than 4 times weekly whose delivered dose of hemodialysis (calculated from the last measurements of the month using the UKM or Daugirdas II formula) was a spKt/V greater than or equal to 1.2 during the study period. This updates a previously published measure summary.
- End stage renal disease (ESRD): percentage of all peritoneal dialysis and hemodialysis patient-months with serum or plasma phosphorus measured at least once within the month.
- End stage renal disease (ESRD): percentage of patient-months for patients on maintenance hemodialysis (HD) during the last HD treatment of the month using an autogenous AV fistula with two needles. This updates a previously published measure summary.
- End stage renal disease (ESRD): percentage of patient-months of pediatric (less than 18 years) in-center hemodialysis patients (irrespective of frequency of dialysis) with documented monthly nPCR measurements.
- End stage renal disease (ESRD): percentage of patient-months of pediatric (less than 18 years) in-center hemodialysis, home hemodialysis, and peritoneal dialysis patients who have monthly measures for hemoglobin during the reporting period.
- End stage renal disease (ESRD): percentage of patient-months on maintenance hemodialysis (HD) during the last HD treatment of the month with a chronic catheter continuously for 90 days or longer prior to the last HD session.This updates a previously published measure summary.
- End stage renal disease (ESRD): percentage of pediatric peritoneal dialysis patient-months with Kt/V greater than or equal to 1.8 Kt/V (dialytic + residual) during the six month study period.
- End stage renal disease (ESRD): percentage of peritoneal dialysis patient-months with Kt/V greater than or equal to 1.7 Kt/V (dialytic + residual) during the four month study period. This updates a previously published measure summary.
- End stage renal disease (ESRD): proportion of all adult patient-months (Medicare and non-Medicare patients) with three-month rolling average of total uncorrected serum or plasma calcium greater than 10.2 mg/dL. This updates a previously published measure summary.
- End stage renal disease (ESRD): risk-adjusted standardized hospitalization ratio (SHR) for dialysis facility patients.This updates a previously published measure summary.
- End stage renal disease (ESRD): risk-adjusted standardized mortality ratio (SMR) for dialysis facility patients. This updates a previously published measure summary.
- End stage renal disease (ESRD): risk-adjusted standardized readmission ratio (SRR) for dialysis facility patients.
- End stage renal disease (ESRD): risk-adjusted standardized transfusion ratio (STrR) for dialysis facility patients.This updates a previously published measure summary.
.png)
No hay comentarios:
Publicar un comentario